The Mesh of the Generics and the Potential of Emerging Therapies in the Smoking Cessation Market
Delveinsight
FEBRUARY 5, 2021
Some of these approved products contain nicotine as an active ingredient, while others do not. Moreover, the generic drugs of Zyban are also approved, while for Chantix, its patent is soon going to expire in 2021 in the EU and in 2022 in Japan. Generics in the Market. Smoking Cessation Emerging Therapies.
Let's personalize your content